相关实验视频

Updated: May 30, 2025

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

瘤微环境中的中性粒细胞的代谢重编程:新兴的治疗点

Shiyun Huang¹, Jiahao Shi¹, Jianfeng Shen¹

¹Department of Ophthalmology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China; Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, 200025, China.

|January 25, 2025

概括

中性粒细胞在瘤微环境 (TME) 中重新编程其新陈代谢,以支持癌症的进展. 针对这些代谢途径提供了一种新的策略,通过调节中性粒细胞功能来增强癌症免疫治疗.

科学领域:

免疫学免疫学免疫学
癌症生物学癌症生物学
代谢研究研究代谢研究

背景情况:

中性粒细胞是关键的免疫细胞,与癌症发展有关.
瘤微环境 (TME) 诱导中性粒细胞发生显著的代谢变化.
中性粒细胞的代谢重编程对于它们在癌症中的免疫抑制功能至关重要.

研究的目的:

审查中性粒细胞在TME中的代谢重编程.
阐明涉及的分子机制和信号通路.
讨论研究癌症中性粒细胞代谢的挑战和新出现的解决方案.

主要方法:

文献综述综合了当前关于中性粒细胞代谢在TME中的研究.
分析驱动代谢重编程的分子机制和信号通路.
讨论该领域的方法挑战和进展.

主要成果:

中性粒细胞从有氧新陈代谢转变为改变的糖解,脂质,线粒体和氨基酸代谢在TME.
这种代谢重编程有助于瘤的进展和免疫抑制.
特定的分子通路控制这些代谢适应.

结论:

中性粒细胞的代谢重编程是TME在癌症中的功能不可或缺的一部分.
向中性粒细胞代谢途径为癌症治疗提供了一个有前途的新策略.
克服研究挑战是开发有效免疫疗法的关键.

关键词:

代谢过程中的代谢.作为一个中性粒细胞.治疗疗法治疗疗法瘤微环境是一个微环境.

更多相关视频

Isolation and Characterization of Neutrophils with Anti-Tumor Properties

Isolation and Characterization of Neutrophils with Anti-Tumor Properties

Published on: June 19, 2015

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents

Published on: March 25, 2016

相关概念视频

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...